Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 1/2007

01-01-2007 | RESEARCH ARTICLES

Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer

Authors: Antonio Rodríguez Fernández, Manuel Gómez Río, José Manuel Llamas Elvira, Abel Sánchez-Palencia Ramos, María Bellón Guardia, Carlos Ramos Font, Pablo Torné Poyatos, Vicente Pedraza Muriel

Published in: Clinical and Translational Oncology | Issue 1/2007

Login to get access
Metadata
Title
Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer
Authors
Antonio Rodríguez Fernández
Manuel Gómez Río
José Manuel Llamas Elvira
Abel Sánchez-Palencia Ramos
María Bellón Guardia
Carlos Ramos Font
Pablo Torné Poyatos
Vicente Pedraza Muriel
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 1/2007
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-007-0007-6

Other articles of this Issue 1/2007

Clinical and Translational Oncology 1/2007 Go to the issue

RESEARCH ARTICLES

Long term results of a phase II trial of Induction Chemotherapy with Uracil-Ftegafur (UFT), Vinorelbine and Cisplatin (UFTVP) followed by Radiotherapy concomitant with UFT and Carboplatin (RT/UFTJ) in Non-Resectable Locally Advanced (Stage IV-B) Squamous Cell Head and Neck Carcinoma and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia

NEWS AND VIEWS

The atomic world and cancer

EDUCATIONAL SERIES

Molecular biology of bladder cancer

RESEARCH ARTICLES

Clinical outcome after surgical resection of lung metastases from melanoma

EDUCATIONAL SERIES

Tumour cells resistance in cancer therapy

CORRESPONDENCE

Superficial Thrombophlebitis As An Exceptional Complication Of A Scrotal Arteriovenous Malformation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits